Development of Chimeric Hepatitis B (HBV) – Norovirus (NoV) P particle as candidate vaccine against Hepatitis B and norovirus infection

INTRODUCTION: Hepatitis B remains a global problem with no effective treatment. Here, a mucosal vaccine candidate was developed with HBsAg and HBcAg, to provide both prophylactic and therapeutic protection against hepatitis B. The antigens were presented using the P particle of human norovirus (HuNo...

Descripción completa

Detalles Bibliográficos
Autores principales: Giri-Rachman, Ernawati Arifin, Irasonia Tan, Marselina, Ramesh, Ashwin, Fajar, Putri Ayu, Nurul Ilmi, Annisa, Retnoningrum, Debbie Sofie, Hertadi, Rukman, Irawan, Apriliani, Wojciechowska, Gladys Emmanuella Putri, Yuan, Lijuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Regular paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372314/
https://www.ncbi.nlm.nih.gov/pubmed/37519778
http://dx.doi.org/10.1016/j.jvacx.2023.100354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372314/
https://www.ncbi.nlm.nih.gov/pubmed/37519778
http://dx.doi.org/10.1016/j.jvacx.2023.100354

Ejemplares similares